Role of Nrf2 in protection against triptolide-induced toxicity in rat kidney cells

Toxicology Letters

Volumn 213, Issue 2, 2012, Pages 194-202

  Li, Jia ^a   Jin, Jing ^a   Li, Mei ^a   Guan, Cuiwen ^a   Wang, Wenwen ^a   Zhu, Shaohua ^a   Qiu, Yuwen ^a   Huang, Min ^a   Huang, Zhiying ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Nrf2; NRK 52E cells; Oxidative stress; Renal injury; Triptolide

Indexed keywords

GLUTATHIONE; LACTATE DEHYDROGENASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TRIPTOLIDE;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; GENE INDUCTION; KIDNEY CELL; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE; CELL SURVIVAL; DITERPENES; EPOXY COMPOUNDS; GLUTATHIONE; KIDNEY; L-LACTATE DEHYDROGENASE; MICROSCOPY, PHASE-CONTRAST; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHENANTHRENES; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

RATTUS; TRIPTERYGIUM WILFORDII;

EID: 84864396552     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.07.008     Document Type: Article

References (46)

1. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews 2008, 60:79-127.
2. Aleksunes L.M., Goedken M.J., Rockwell C.E., Thomale J., Manautou J.E., Klaassen C.D. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. Journal of Pharmacology and Experimental Therapeutics 2010, 335:2-12.
3. Aoki Y., Sato H., Nishimura N., Takahashi S., Itoh K., Yamamoto M. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicology and Applied Pharmacology 2001, 173:154-160.
4. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Archives of Toxicology 2011, 85:241-272.
5. Balogun E., Hoque M., Gong P., Killeen E., Green C.J., Foresti R., Alam J., Motterlini R. Curcumin activates the heme oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Journal 2003, 371:887-895.
6. Boesch-Saadatmandi C., Wagner A.E., Graeser A.C., Hundhausen C., Wolffram S., Rimbach G. Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells. Journal of Animal Physiology and Animal Nutrition 2009, 93:547-554.
7. Chen C., Kong A.N. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radical Biology and Medicine 2004, 36:1505-1516.
8. Chen J., Shaikh Z.A. Activation of Nrf2 by cadmium and its role in protection against cadmium-induced apoptosis in rat kidney cells. Toxicology and Applied Pharmacology 2009, 241:81-89.
9. Das J., Ghosh J., Roy A., Sil P.C. Mangiferin exerts hepatoprotective activity against d-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFkappaB pathways. Toxicology and Applied Pharmacology 2012, 260:35-47.
10. Dinkova-Kostova A.T., Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Archives of Biochemistry and Biophysics 2010, 501:116-123.
11. Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O'Connor T., Harada T., Yamamoto M. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicological Sciences 2001, 59:169-177.
12. Gao Q., Shen W., Qin W., Zheng C., Zhang M., Zeng C., Wang S., Wang J., Zhu X., Liu Z. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2010, 25:3539-3547.
13. Graziose R., Lila M.A., Raskin I. Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Current Drug Discovery Technologies 2010, 7:2-12.
14. Guerrero-Beltran C.E., Calderon-Oliver M., Tapia E., Medina-Campos O.N., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Ortiz-Vega K.M., Franco M., Pedraza-Chaverri J. Sulforaphane protects against cisplatin-induced nephrotoxicity. Toxicology Letters 2010, 192:278-285.
15. Guo J.L., Yuan S.X., Wang X.C., Xu S.X., Li D.D. Tripterygium wilfordii Hook f. in rheumatoid arthritis and ankylosing spondylitis. Preliminary report. Chinese Medical Journal 1981, 94:405-412.
16. Kalayarasan S., Prabhu P.N., Sriram N., Manikandan R., Arumugam M., Sudhandiran G. Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats. European Journal of Pharmacology 2009, 606:162-171.
17. Kang K.W., Lee S.J., Kim S.G. Molecular mechanism of nrf2 activation by oxidative stress. Antioxidants and Redox Signalling 2005, 7:1664-1673.
18. Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radical Biology and Medicine 2009, 47:1304-1309.
19. Kawabata T., Ma Y., Yamador I., Okada S. Iron-induced apoptosis in mouse renal proximal tubules after an injection of a renal carcinogen, iron-nitrilotriacetate. Carcinogenesis 1997, 18:1389-1394.
20. Kobayashi M., Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidants and Redox Signalling 2005, 7:385-394.
21. Kupchan S.M., Court W.A., Dailey R.G., Gilmore C.J., Bryan R.F. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. Journal of the American Chemical Society 1972, 94:7194-7195.
22. Lee J.M., Li J., Johnson D.A., Stein T.D., Kraft A.D., Calkins M.J., Jakel R.J., Johnson J.A. Nrf2, a multi-organ protector?. FASEB Journal 2005, 19:1061-1066.
23. Lee M.W., Park S.C., Yang Y.G., Yim S.O., Chae H.S., Bach J.H., Lee H.J., Kim K.Y., Lee W.B., Kim S.S. The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis. FEBS Letters 2002, 512:313-318.
24. Leuenroth S.J., Okuhara D., Shotwell J.D., Markowitz G.S., Yu Z., Somlo S., Crews C.M. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4389-4394.
25. Li L.S. Clinical and experimental studies on the effect of Tripterygium wilfordii Hook in the treatment of nephritis. Zhonghua Yi Xue Za Zhi 1982, 62:581-585.
26. Li W., Kong A.N. Molecular mechanisms of Nrf2-mediated antioxidant response. Molecular Carcinogenesis 2009, 48:91-104.
27. Liu L., Wang Z.Y., Huang G.Z., Liu Y. The influence of triptolide sub-chronic intoxication on kidney and testicle in mice. Acta Universitatis Medicinae Tongji 2001, 30:214-217.
28. Lu H., Hachida M., Enosawa S., Li X.K., Suzuki S., Koyanagi H. Immunosuppressive effect of triptolide in vitro. Transplantation Proceedings 1999, 31:2056-2057.
29. Luo Y.W., Shi C., Yuan Y., Zhang M., Liao M.Y. Research progress on the toxicity of triptolide. Journal of Toxicology 2009, 23:74-77.
30. Park H.M., Cho J.M., Lee H.R., Shim G.S., Kwak M.K. Renal protection by 3H-1,2-dithiole-3-thione against cisplatin through the Nrf2-antioxidant pathway. Biochemical Pharmacology 2008, 76:597-607.
31. Rubio V., Zhang J., Valverde M., Rojas E., Shi Z.Z. Essential role of Nrf2 in protection against hydroquinone- and benzoquinone-induced cytotoxicity. Toxicology In Vitro 2011, 25:521-529.
32. Sahin K., Tuzcu M., Gencoglu H., Dogukan A., Timurkan M., Sahin N., Aslan A., Kucuk O. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sciences 2010, 87:240-245.
33. Saw C.L., Cintron M., Wu T.Y., Guo Y., Huang Y., Jeong W.S., Kong A.N. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharmaceutics and Drug Disposition 2011, 32:289-300.
34. Shamon L.A., Pezzuto J.M., Graves J.M., Mehta R.R., Wangcharoentrakul S., Sangsuwan R., Chaichana S., Tuchinda P., Cleason P., Reutrakul V. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Letters 1997, 112:113-117.
35. Shin D.H., Park H.M., Jung K.A., Choi H.G., Kim J.A., Kim D.D., Kim S.G., Kang K.W., Ku S.K., Kensler T.W., Kwak M.K. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radical Biology and Medicine 2010, 48:1051-1063.
36. Shu B., Duan W., Yao J., Huang J., Jiang Z., Zhang L. Caspase 3 is involved in the apoptosis induced by triptolide in HK-2 cells. Toxicology In Vitro 2009, 23:598-602.
37. Sun R., Wu X.D., Liu J.W., Sun L., Lv L.L. Experimental study of the rat renal toxicity of Tripterygium wilfordii, Caulis aristolochiae and Leonurus. Pharmacology and Clinics of Chinese Materia Medica 2005, 21:26-28.
38. Tan K.P., Kosuge K., Yang M., Ito S. NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity. Free Radical Biology and Medicine 2008, 45:1663-1673.
39. Wang Z., Jin H., Li C., Hou Y., Mei Q., Fan D. Heat shock protein 72 protects kidney proximal tubule cells from injury induced by triptolide by means of activation of the MEK/ERK pathway. International Journal of Toxicology 2009, 28:177-189.
40. Yang F., Ren L., Zhuo L., Ananda S., Liu L. Involvement of oxidative stress in the mechanism of triptolide-induced acute nephrotoxicity in rats. Experimental and Toxicologic Pathology 2011.
41. Yao J.W., Liu J., Kong X.Z., Zhang S.G., Wang X.H., Yu M., Zhan Y.Q., Li W., Xu W.X., Tang L.J., Ge C.H., Wang L., Li C.Y., Yang X.M. Induction of activation of the antioxidant response element and stabilization of Nrf2 by 3-(3-pyridylmethylidene)-2-indolinone (PMID) confers protection against oxidative stress-induced cell death. Toxicology and Applied Pharmacology 2012, 259:227-235.
42. Ye X., Li W., Yan Y., Mao C., Cai R., Xu H., Yang X. Effects of cytochrome P4503A inducer dexamethasone on the metabolism and toxicity of triptolide in rat. Toxicology Letters 2010, 192:212-220.
43. Yilmaz H.R., Iraz M., Sogut S., Ozyurt H., Yildirim Z., Akyol O., Gergerlioglu S. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacological Research 2004, 50:287-290.
44. Yuan X.P., He X.S., Wang C.X., Liu L.S., Fu Q. Triptolide attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrology (Carlton) 2011, 16:200-210.
45. Zheng Y.L., Lin J.F., Lin C.C., Xu Y. Anti-inflammatory effect of triptolide. Zhongguo Yao Li Xue Bao 1994, 15:540-543.
46. Zhu T.Z., Lu C.Y. Nephrotoxicity in traditional Chinese medicine. Chinese Journal of Nephrology 1991, 7:90.